Cargando…

HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy

Anti-HER2/neu antibody therapy has been reported to mediate tumor regression of HER2/ neu(+) tumors. Here we demonstrated the expression of HER2 in a wide range of human melanoma cells including a primary culture and seven cell lines, and we further investigated whether HER2 could be served as a tar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Juan, Han, Huamin, Liu, Deruo, li, Wei, Feng, Hongxiang, Xue, Xin, Wu, Xiaoran, Niu, Ge, Zhang, Ge, Zhao, Yunfeng, Liu, Changzhen, Tao, Hua, Gao, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754977/ https://www.ncbi.nlm.nih.gov/pubmed/24015299 http://dx.doi.org/10.1371/journal.pone.0073261

Ejemplares similares

Correction: HER2 as a Promising Target for Cytotoxicity T Cells in Human Melanoma Therapy
por: Ma, Juan, et al.
Publicado: (2013)

B7-H3 as a promising target for cytotoxicity T cell in human cancer therapy
por: Ma, Juan, et al.
Publicado: (2016)

Retargeting T Cells for HER2-Positive Tumor Killing by a Bispecific Fv-Fc Antibody
por: Wang, Lei, et al.
Publicado: (2013)

Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptor
por: Zhang, Ge, et al.
Publicado: (2014)

MiR‐34b‐3p represses cell proliferation, cell cycle progression and cell apoptosis in non‐small‐cell lung cancer (NSCLC) by targeting CDK4
por: Feng, Hongxiang, et al.
Publicado: (2019)

The immunostimulatory effects of retinoblastoma cell supernatant on dendritic cells
por: Ma, Juan, et al.
Publicado: (2014)

Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor
por: Hu, Zexi, et al.
Publicado: (2015)

Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor
por: Hu, Zexi, et al.
Publicado: (2018)

Clinicopathological characteristics of solitary cavitary lung cancer: a case-control study
por: Liu, Zhan, et al.
Publicado: (2020)

Pulmonary mucormycosis: a case of pulmonary arterial hypertension, Westermark sign, and bronchopleural fistula
por: Shao, Weipeng, et al.
Publicado: (2020)

Detection of SHOX2 DNA methylation by methylation-specific PCR in non-small cell lung cancer
por: Feng, Hongxiang, et al.
Publicado: (2020)

Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
por: Conradi, Lena-Christin, et al.
Publicado: (2019)

Charlson comorbidity index as a predictor of short-term outcomes after pulmonary resection
por: Shao, Weipeng, et al.
Publicado: (2020)

Comprehensive Analysis of a Novel Immune-Related Gene Signature in Lung Adenocarcinoma
por: Feng, Hongxiang, et al.
Publicado: (2022)

Prognostic Value of Plasma HER2 Gene Copy Number in HER2-Positive Metastatic Breast Cancer Treated with First-Line Trastuzumab
por: Ran, Ran, et al.
Publicado: (2020)

Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro
por: Liu, Zhe, et al.
Publicado: (2012)

The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas()
por: Wang, Hongxiang, et al.
Publicado: (2015)

HER2 status of CTCs by peptide-functionalized nanoparticles as the diagnostic biomarker of breast cancer and predicting the efficacy of anti-HER2 treatment
por: Wang, Mengting, et al.
Publicado: (2022)

EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma
por: Capone, Emily, et al.
Publicado: (2017)

Characteristics of pulmonary mucormycosis and the experiences of surgical resection
por: Shao, Weipeng, et al.
Publicado: (2020)

The extracellular vesicles targeting tumor microenvironment: a promising therapeutic strategy for melanoma
por: Li, Yongmin, et al.
Publicado: (2023)

Melatonin potentiates the cytotoxic effect of Neratinib in HER2(+) breast cancer through promoting endocytosis and lysosomal degradation of HER2
por: Liu, Zundong, et al.
Publicado: (2021)

The Nrf2 inhibitor brusatol synergistically enhances the cytotoxic effect of lapatinib in HER2-positive cancers
por: Tian, Ziyin, et al.
Publicado: (2022)

Tracheal Carinal Reconstruction and Bronchovasculoplasty in Central Type Bronchogenic Carcinoma
por: LIU, Deruo, et al.
Publicado: (2010)

ZWZ-3, a Fluorescent Probe Targeting Mitochondria for Melanoma Imaging and Therapy
por: Liu, Zengjin, et al.
Publicado: (2022)

Targeting the FGFR signaling pathway in cholangiocarcinoma: promise or delusion?
por: Wang, Jing, et al.
Publicado: (2020)

Targeting HER3 or MEK overcomes acquired Trastuzumab resistance in HER2-positive gastric cancer-derived xenograft
por: Zhang, Mengqi, et al.
Publicado: (2022)

Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in Melanoma
por: Liu, Nian, et al.
Publicado: (2020)

BAP31, a promising target for the immunotherapy of malignant melanomas
por: Yu, Shaojuan, et al.
Publicado: (2015)

Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers
por: Punnia-Moorthy, Gaya, et al.
Publicado: (2021)

Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer
por: Li, Feifei, et al.
Publicado: (2022)

Prognostic value of neuron-specific enolase for small cell lung cancer: a systematic review and meta-analysis
por: Tian, Zhoujunyi, et al.
Publicado: (2020)

Impact of interstitial lung disease on postoperative morbidity and 90-day mortality after pulmonary resection
por: Shao, Weipeng, et al.
Publicado: (2020)

Correction: Uniportal video-assisted anatomical segmentectomy: an analysis of the learning curve
por: Han, Yu, et al.
Publicado: (2023)

Uniportal video-assisted anatomical segmentectomy: an analysis of the learning curve
por: Han, Yu, et al.
Publicado: (2023)

Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B
por: Iacovino, Luca G., et al.
Publicado: (2021)

Epac: A Promising Therapeutic Target for Vascular Diseases: A Review
por: Pan, Yunfeng, et al.
Publicado: (2022)

Effects of T-cadherin expression on B16F10 melanoma cells
por: DUAN, XIN-SUO, et al.
Publicado: (2013)

6-lncRNA Assessment Model for Monitoring and Prognosis of HER2-Positive Breast Cancer: Based on Transcriptome Data
por: Zhang, Xiaoming, et al.
Publicado: (2021)

NOX4 Signaling Mediates Cancer Development and Therapeutic Resistance through HER3 in Ovarian Cancer Cells
por: Liu, Wen-Jing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j7ivd584gogoq1uchnbmoaoqdg